Vickram Ramkumar

Affiliated with

Research Area

Biography

Vickram Ramkumar has not added Biography.
If you are Vickram Ramkumar and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 12	2018

Other Publications

Article	Year
Adenosine, oxidative stress and cytoprotection. Japanese journal of pharmacology\| PubMed ID: 11488425	2001
Cisplatin up-regulates the adenosine A(1) receptor in the rat kidney. European journal of pharmacology\| PubMed ID: 12065079	2002
Hsp70 in the inferior colliculus of Fischer-344 rats: effects of age and acoustic stress. Hearing research\| PubMed ID: 12208549	2002
Hypertonicity inhibits lipopolysaccharide-induced nitric oxide synthase expression in smooth muscle cells by inhibiting nuclear factor kappaB. Molecular pharmacology\| PubMed ID: 12761333	2003
Noise induces A1 adenosine receptor expression in the chinchilla cochlea. Hearing research\| PubMed ID: 14759570	2004
Direct interaction of adenosine with the TRPV1 channel protein. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 15071115	2004
Protection against cisplatin ototoxicity by adenosine agonists. Biochemical pharmacology\| PubMed ID: 15081879	2004
Osmotic diuretics induce adenosine A1 receptor expression and protect renal proximal tubular epithelial cells against cisplatin-mediated apoptosis. The Journal of biological chemistry\| PubMed ID: 15272017	2004
Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear fact... The Journal of pharmacology and experimental therapeutics\| PubMed ID: 16188954	2006
Essential role of Rac1/NADPH oxidase in nerve growth factor induction of TRPV1 expression. Journal of neurochemistry\| PubMed ID: 16283857	2005
Induction of adenosine A1 receptor expression by pertussis toxin via an adenosine 5'-diphosphate ribosylation-independent pathway. The Journal of pharmacology and experimental therapeutics\| PubMed ID: 16322354	2006
Nitric oxide serves as an endogenous regulator of neuronal adenosine A1 receptor expression. Journal of neurochemistry\| PubMed ID: 16987234	2006
Activation of the adenosine A1 receptor inhibits HIV-1 tat-induced apoptosis by reducing nuclear factor-kappaB activation and inducible nitric-oxide synthase. Molecular pharmacology\| PubMed ID: 17609415	2007
Expression of striatal adenosine and dopamine receptors in mice deficient in the p50 subunit of NF-kappaB. Life sciences\| PubMed ID: 17869311	2007
Adenosine and dopamine receptor interactions in striatum and caffeine-induced behavioral activation. Comparative medicine\| PubMed ID: 18246865	2007
Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 19052196	2008
Role of beta-arrestin1/ERK MAP kinase pathway in regulating adenosine A1 receptor desensitization and recovery. American journal of physiology. Cell physiology\| PubMed ID: 19828838	2010
Cisplatin ototoxicity and protection: clinical and experimental studies. The Tohoku journal of experimental medicine\| PubMed ID: 19851045	2009
Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity. Neoplasia (New York, N.Y.)\| PubMed ID: 19881949	2009
Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat. Antioxidants & redox signaling\| PubMed ID: 20214492	2010
Lack of association of a spontaneous mutation of the Chrm2 gene with behavioral and physiologic phenotypic differences in inbred mice. Comparative medicine\| PubMed ID: 20819376	2010
Nuclear Factor κB and Adenosine Receptors: Biochemical and Behavioral Profiling. Current neuropharmacology\| PubMed ID: 22131942	2011
The design and screening of drugs to prevent acquired sensorineural hearing loss. Expert opinion on drug discovery\| PubMed ID: 22646075	2011
Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway. PloS one\| PubMed ID: 23272133	2012
Essential Role of NADPH Oxidase-Dependent Reactive Oxygen Species Generation in Regulating MicroRNA-21 Expression and Function in Prostate Cancer. Antioxidants & redox signaling\| PubMed ID: 23682737	2013
Adenosine receptors: expression, function and regulation. International journal of molecular sciences\| PubMed ID: 24477263	2014
TRPV1: A Potential Drug Target for Treating Various Diseases. Cells\| PubMed ID: 24861977	2014
Early investigational drugs for hearing loss. Expert opinion on investigational drugs\| PubMed ID: 25243609	2015
Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 27053204	2016
Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol. PloS one\| PubMed ID: 28467474	2017
Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity. Cell death & disease\| PubMed ID: 28703809	2017
Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection. Frontiers in cellular neuroscience\| PubMed ID: 29163050	2017